Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation
- PMID: 29622159
- DOI: 10.1016/j.jacc.2018.01.076
Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation
Abstract
Background: Transcatheter left atrial appendage (LAA) occlusion is an alternative strategy for stroke prevention in patients with atrial fibrillation (AF).
Objectives: This study sought to determine the incidence, predictors, and prognosis of thrombus formation on devices in patients with AF who were treated with LAA closure.
Methods: The study retrospectively analyzed data from patients treated with 2 LAA closure devices seen in 8 centers in France from February 2012 to January 2017.
Results: A total of 469 consecutive patients with AF underwent LAA closure (272 Watchman devices [Atritech, Boston Scientific, Natick, Massachusetts] and 197 Amplatzer devices [St. Jude Medical, Minneapolis, Minnesota]). Mean follow-up was 13 ± 13 months, during which 339 (72.3%) patients underwent LAA imaging at least once. There were 98 major adverse events (26 thrombi on devices, 19 ischemic strokes, 2 transient ischemic attacks, 18 major hemorrhages, 33 deaths) recorded in 89 patients. The incidence of device-related thrombus in patients with LAA imaging was 7.2% per year. Older age (hazard ratio [HR]: 1.07 per 1-year increase; 95% confidence interval [CI]: 1.01 to 1.14; p = 0.02) and history of stroke (HR: 3.68; 95% CI: 1.17 to 11.62; p = 0.03) were predictors of thrombus formation on the devices, whereas dual antiplatelet therapy (HR: 0.10; 95% CI: 0.01 to 0.76; p = 0.03) and oral anticoagulation at discharge (HR: 0.26; 95% CI: 0.09 to 0.77; p = 0.02) were protective factors. Thrombus on the device (HR: 4.39; 95% CI: 1.05 to 18.43; p = 0.04) and vascular disease (HR: 5.03; 95% CI: 1.39 to 18.23; p = 0.01) were independent predictors of ischemic strokes and transient ischemic attacks during follow-up.
Conclusions: Thrombus formation on the device is not uncommon in patients with AF who are treated by LAA closure. Such events are strongly associated with a higher risk of ischemic stroke during follow-up. (REgistry on Real-Life EXperience With Left Atrial Appendage Occlusion [RELEXAO]; NCT03279406).
Keywords: antithrombotic therapy; embolism; stroke; thrombus on device; transesophageal echocardiography; transient ischemic attack.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Left Atrial Appendage Occlusion Device-Related Thrombus: Certainties and Uncertainties.J Am Coll Cardiol. 2018 Apr 10;71(14):1537-1539. doi: 10.1016/j.jacc.2018.01.077. J Am Coll Cardiol. 2018. PMID: 29622160 No abstract available.
-
A Call for Standardization in Left Atrial Appendage Occlusion.J Am Coll Cardiol. 2018 Jul 24;72(4):472-473. doi: 10.1016/j.jacc.2018.04.075. J Am Coll Cardiol. 2018. PMID: 30025583 No abstract available.
-
Suboptimal Device Implantation May Increase the Occurrence of Device Thrombosis After Left Atrial Appendage Occlusion.J Am Coll Cardiol. 2018 Jul 24;72(4):473-474. doi: 10.1016/j.jacc.2018.04.076. J Am Coll Cardiol. 2018. PMID: 30025584 No abstract available.
-
Reply: Device-Related Thrombus After Percutaneous Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.J Am Coll Cardiol. 2018 Jul 24;72(4):474-475. doi: 10.1016/j.jacc.2018.05.028. J Am Coll Cardiol. 2018. PMID: 30025585 No abstract available.
-
Left atrial appendage closure: prevalence and risk of device-associated thrombus formation.Cardiovasc Diagn Ther. 2019 Feb;9(1):104-109. doi: 10.21037/cdt.2018.10.05. Cardiovasc Diagn Ther. 2019. PMID: 30881888 Free PMC article. No abstract available.
Similar articles
-
Extending percutaneous left atrial appendage closure indications using the AMPLATZER™ Cardiac Plug device in patients with persistent left atrial appendage thrombus: The thrombus trapping technique.Arch Cardiovasc Dis. 2016 Dec;109(12):659-666. doi: 10.1016/j.acvd.2016.02.012. Epub 2016 Jul 8. Arch Cardiovasc Dis. 2016. PMID: 27402154
-
Thrombus Formation After Left Atrial Appendage Occlusion With the Amplatzer Amulet Device.JACC Clin Electrophysiol. 2017 Jan;3(1):71-75. doi: 10.1016/j.jacep.2016.05.006. Epub 2016 Jul 27. JACC Clin Electrophysiol. 2017. PMID: 29759698
-
The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.J Am Coll Cardiol. 2012 Mar 6;59(10):923-9. doi: 10.1016/j.jacc.2011.11.028. J Am Coll Cardiol. 2012. PMID: 22381428 Clinical Trial.
-
[Percutaneous closure of left atrial appendage in non-valvular atrial fibrillation--international and Hungarian experiences].Orv Hetil. 2010 May 2;151(18):725-34. doi: 10.1556/OH.2010.28870. Orv Hetil. 2010. PMID: 20409999 Review. Hungarian.
-
Device-associated thrombus formation after left atrial appendage occlusion: A systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet.Catheter Cardiovasc Interv. 2017 Nov 1;90(5):E111-E121. doi: 10.1002/ccd.26903. Epub 2017 Feb 1. Catheter Cardiovasc Interv. 2017. PMID: 28145040 Review.
Cited by
-
Predictors of Device-Related Thrombus After Left Atrial Appendage Occlusion: TED-F2 Score.CJC Open. 2024 Jun 14;6(10):1153-1161. doi: 10.1016/j.cjco.2024.05.015. eCollection 2024 Oct. CJC Open. 2024. PMID: 39525332 Free PMC article.
-
Clinical and subclinical acute brain injury caused by invasive cardiovascular procedures.Nat Rev Cardiol. 2024 Oct 11. doi: 10.1038/s41569-024-01076-0. Online ahead of print. Nat Rev Cardiol. 2024. PMID: 39394524 Review.
-
Late-onset left atrial appendage occlusion device-related thrombus attributed to mitral bioprosthetic stenosis: a case report.Eur Heart J Case Rep. 2024 Aug 23;8(9):ytae438. doi: 10.1093/ehjcr/ytae438. eCollection 2024 Sep. Eur Heart J Case Rep. 2024. PMID: 39258025 Free PMC article.
-
Echocardiographic assessment of left atrial appendage morphology and function-an expert proposal by the German Working Group of Cardiovascular Ultrasound.Clin Res Cardiol. 2024 Aug 28. doi: 10.1007/s00392-024-02492-5. Online ahead of print. Clin Res Cardiol. 2024. PMID: 39196343 Review.
-
A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study.EuroIntervention. 2024 Aug 19;20(16):1018-1028. doi: 10.4244/EIJ-D-24-00116. EuroIntervention. 2024. PMID: 39155755
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
